Suncast Solar Energy (OTCMKTS:SUNC) & NeoGenomics (NASDAQ:NEO) Critical Analysis

0 N/A
NeoGenomics currently has a consensus price target of $40.95, indicating a potential downside of 9.21%. Given NeoGenomics’ higher possible upside, equities research analysts plainly believe NeoGenomics is more favorable than Suncast Solar Energy.
Summary
NeoGenomics beats Suncast Solar Energy on 7 of the 10 factors compared between the two stocks.
NeoGenomics Company Profile
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, as well as laborat…

Original Source